Private ADHD Prescribing UK 2026: Complete Guide to Costs, Process & Shared Care
Everything you need to know about private ADHD prescribing in the UK: costs £50-160/month, assessment £500-1200, shared care agreements, GP acceptance, and how to choose the right clinic.
ADHD Medication UK Adults 2026: Complete Guide to Treatments, Costs & NHS Options
Discover everything UK adults need to know about ADHD medication in 2026: NHS vs private treatment, stimulant & non-stimulant options, costs, side effects, and how to start treatment.
Nurse Prescriber ADHD Medication UK: Complete Guide to Nurse-Led ADHD Care
Discover how nurse prescribers in the UK can diagnose ADHD and prescribe medication. Learn about qualifications, costs, wait times, and why nurse-led ADHD care is growing.
ADHD Medication Review Template Primary Care: Complete GP Guide, Checklist & FAQs
Need an ADHD medication review template for primary care? Get a comprehensive GP checklist, monitoring requirements, NICE guidelines compliance, and FAQs for safe ADHD reviews.
Weiss Functional Impairment Scale for ADHD: The Complete Guide to Measuring Real-World Impact
Understanding the Weiss Functional Impairment Scale (WFIRS) for ADHD? Learn what it measures, how scoring works, why it matters for treatment, and answers to common patient FAQs.
ADHD Annual Review NICE NG87: Complete Guide, Checklist & FAQs for Patients
Understanding ADHD annual reviews under NICE NG87 guidelines? Learn what's included, how often reviews are needed, monitoring requirements, and answers to common patient FAQs.
ADHD Shared Care Protocol with Nurse Prescribers: The Complete Guide & FAQs
Understanding ADHD shared care protocols with nurse prescribers? Learn what they are, how they work, your rights, monitoring requirements, and answers to common patient FAQs.
Atomoxetine and QT Prolongation: What ADHD Patients Need to Know About Heart Safety
Learn about atomoxetine (Strattera) and QT prolongation risks, cardiac side effects, monitoring recommendations, and who should avoid this ADHD medication. Expert-backed FAQs included.
Atomoxetine QT Prolongation: What Patients and Clinicians Should Know
Learn what atomoxetine QT prolongation means, who may be at risk, how to monitor heart safety, and when to seek medical advice.
Methylphenidate vs Lisdexamfetamine in Adults: Benefits, Side Effects, and How to Choose
Compare methylphenidate vs lisdexamfetamine for adults with ADHD, including effectiveness, side effects, duration, FAQs, and key decision factors.
ADHD Medication Initiation Checklist: What to Do Before, During, and After Starting Treatment
Learn what to ask, track, and prepare before starting ADHD medication with this practical initiation checklist, FAQs, and safety tips.
Elvanse Prescribing Guidelines for Adults: Safe ADHD Treatment in the UK
Learn the key Elvanse prescribing guidelines for adults in the UK, including assessment, monitoring, contraindications, titration, shared care and FAQs.
Lisdexamfetamine Contraindications UK: What Clinicians and Patients Need to Know
Learn the main lisdexamfetamine contraindications in the UK, including cardiovascular, psychiatric and medication risks, plus FAQs and safety guidance.
Weiss ADHD Review Tool: A Practical Guide for Adult ADHD Assessment
Discover how the Weiss ADHD review tool supports adult ADHD assessment, symptom review, impairment tracking and safer treatment decisions in clinical practice.
ADHD Clinical Decision Support UK: Improving Safety, Consistency, and Confidence in ADHD Care
Explore ADHD clinical decision support in the UK, including NICE-aligned assessment, prescribing, monitoring, and safer ADHD care pathways for clinicians and patients.
Methylphenidate Contraindications Checker: A Prescriber’s Guide to Safe ADHD Treatment
Use this methylphenidate contraindications checker guide to identify who should not take methylphenidate, key red flags, safety checks, and prescriber considerations.
ADHD Initiation Checklist for Prescribers: A Practical, Safe, and Evidence-Based Guide
A complete ADHD initiation checklist for prescribers. Learn safe, evidence-based steps for assessment, medication initiation, and monitoring in ADHD care.
The ADHD Prescription That Goes Wrong — Are You Covered?
Nobody goes into a consultation intending to miss something. But when a complaint is made, the question isn't whether you're a good clinician. It's whether you can demonstrate — from your records — that you did everything that should have been done. That distinction is the difference between a defensible complaint and a referral to the NMC.
ADHD Shared Care Protocol Tool: A Guide for Safer Shared Prescribing
Learn how an ADHD shared care protocol tool supports safer prescribing, monitoring, and communication between specialist and GP in adult ADHD care.
ADHD Prescribing and Medico-Legal Risk — What Your Documentation Needs to Show
The complaint arrives weeks after the consultation. By then, the prescriber is trying to reconstruct what happened from notes that say "contraindications checked — suitable to proceed." That note is not a defence. It's a conclusion without any evidence of the process that led to it. Here's what defensible ADHD prescribing documentation actually looks like.